Los puntos clave no están disponibles para este artículo en este momento.
Further studies are needed to address whether the therapies directed toward brain oxidative stress and oxidatively modified key brain proteins might help delay or prevent the progression of AD.
Butterfield et al. (Tue,) studied this question.